Literature DB >> 8896418

Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms.

D Hamann1, P A Baars, B Hooibrink, R W van Lier.   

Abstract

Activation of unprimed CD4+CD45RA+/RO- T cells results in a gradual loss of CD45RA expression concomitant with the acquisition of CD45RO. It has been suggested that this conversion occurs in vivo through a CD45RAbright/RObright stage. Next to this small CD45RAbright/RObright subset (Dbright), a larger subpopulation that expresses both RA and RO isoforms at low levels (Ddull) can be found in the circulating CD4+ T-cell population of all donors. The properties of the latter population are largely undefined. Here, we show that Ddull cells have an intermediate phenotype for antigens such as CD31, CD621, CD58, and CD95 that are differentially expressed on unprimed versus primed T cells. In addition, they are able to provide help for B-cell differentiation and contain substantial numbers of tetanus toxoid (TT)-specific precursor cells. Remarkably, both intracellular cytokine staining and analysis of T-cell clones showed that Ddull cells and CD45RO+ T cells produce comparable high amounts of both interferon (IFN)-gamma and interleukin (IL)-4, which clearly distinguishes them from CD45RA+ and Dbright T cells. Finally, prolonged culture of sorted Ddull cells in a mixture of IL-2, IL-6, and tumor necrosis factor (TNF)-alpha showed that about half of the population retained the Ddull phenotype. Part of the cells upregulated the CD45RA isoform, whereas only a minority switched to single CD45RO expression. Our findings indicate that the Ddull population contains primed T cells, some of which may reacquire an "unprimed" phenotype in the absence of antigenic stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896418

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  In situ activation of helper T cells in the lung.

Authors:  B Raju; C F Tung; D Cheng; N Yousefzadeh; R Condos; W N Rom; D B Tse
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  CD45RA and CD45RO isoforms in infected malnourished and infected well-nourished children.

Authors:  O Nájera; C González; G Toledo; L López; E Cortés; M Betancourt; R Ortiz
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  Homeostasis of the naive CD4+ T cell compartment during aging.

Authors:  Ryan D Kilpatrick; Tammy Rickabaugh; Lance E Hultin; Patricia Hultin; Mary Ann Hausner; Roger Detels; John Phair; Beth D Jamieson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

4.  Avidity of human T cell receptor engineered CD4(+) T cells drives T-helper differentiation fate.

Authors:  Patrick Adair; Yong Chan Kim; Kathleen P Pratt; David W Scott
Journal:  Cell Immunol       Date:  2015-10-23       Impact factor: 4.868

5.  Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia.

Authors:  Amitinder Kaur; Corrina L Hale; Bradley Noren; Nadine Kassis; Meredith A Simon; R Paul Johnson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection.

Authors:  R J Rentenaar; L E Gamadia; N van DerHoek; F N van Diepen; R Boom; J F Weel; P M Wertheim-van Dillen; R A van Lier; I J ten Berge
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

7.  Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers.

Authors:  Chengcheng Zhang; Zhe Wang; Zhi Yang; Meiling Wang; Shiqi Li; Yunyan Li; Rui Zhang; Zhouxing Xiong; Zhihao Wei; Junjie Shen; Yongli Luo; Qianzhen Zhang; Limei Liu; Hong Qin; Wei Liu; Feng Wu; Wei Chen; Feng Pan; Xianquan Zhang; Ping Bie; Houjie Liang; Gabriele Pecher; Cheng Qian
Journal:  Mol Ther       Date:  2017-03-31       Impact factor: 11.454

8.  Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Med Microbiol Immunol       Date:  2015-12-22       Impact factor: 3.402

9.  Memory T-cell responses to Vibrio cholerae O1 infection.

Authors:  Ana A Weil; Mohammad Arifuzzaman; Taufiqur R Bhuiyan; Regina C LaRocque; Aaron M Harris; Emily A Kendall; Azim Hossain; Abdullah A Tarique; Alaullah Sheikh; Fahima Chowdhury; Ashraful I Khan; Farhan Murshed; Kenneth C Parker; Kalyan K Banerjee; Edward T Ryan; Jason B Harris; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

10.  CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype.

Authors:  Sergey A Trushin; Gary D Bren; Andrew D Badley
Journal:  Open Virol J       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.